- Home
- OBIO vs RENE Comparison
OBIO vs RENE Comparison
Compare OBIO & RENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- RENE
- Stock Information
- Founded
- OBIO 2017
- RENE 2021
- Country
- OBIO United States
- RENE United States
- Employees
- OBIO N/A
- RENE N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- RENE Blank Checks
- Sector
- OBIO Health Care
- RENE Finance
- Exchange
- OBIO Nasdaq
- RENE Nasdaq
- Market Cap
- OBIO 151.3M
- RENE 153.8M
- IPO Year
- OBIO N/A
- RENE 2022
- Fundamental
- Price
- OBIO $3.80
- RENE $11.83
- Analyst Decision
- OBIO Strong Buy
- RENE
- Analyst Count
- OBIO 5
- RENE 0
- Target Price
- OBIO $15.40
- RENE N/A
- AVG Volume (30 Days)
- OBIO 51.3K
- RENE 6.1K
- Earning Date
- OBIO 05-12-2025
- RENE 01-01-0001
- Dividend Yield
- OBIO N/A
- RENE N/A
- EPS Growth
- OBIO N/A
- RENE 42.91
- EPS
- OBIO N/A
- RENE 0.43
- Revenue
- OBIO $2,647,000.00
- RENE N/A
- Revenue This Year
- OBIO $22.61
- RENE N/A
- Revenue Next Year
- OBIO $16.64
- RENE N/A
- P/E Ratio
- OBIO N/A
- RENE $27.36
- Revenue Growth
- OBIO N/A
- RENE N/A
- 52 Week Low
- OBIO $3.75
- RENE $11.10
- 52 Week High
- OBIO $8.87
- RENE $11.86
- Technical
- Relative Strength Index (RSI)
- OBIO 37.63
- RENE 79.83
- Support Level
- OBIO $4.14
- RENE $11.77
- Resistance Level
- OBIO $4.67
- RENE $11.78
- Average True Range (ATR)
- OBIO 0.34
- RENE 0.00
- MACD
- OBIO 0.02
- RENE 0.00
- Stochastic Oscillator
- OBIO 9.83
- RENE 100.00
Stock Price Comparison Chart: OBIO vs RENE
■ OBIO
■ RENE
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About RENE Cartesian Growth Corporation II
Cartesian Growth Corp II is a blank check company.
Share on Social Networks:
0